In adults with T2D, eGFR ≥ 60 mL/min/1.73 m2 plus albuminuria (≥ 200 mg/g) or eGFR 30–59 mL/min/1.73 m2 independently of albuminuria and HbA1c above target despite dual therapy, triple therapy with metformin, SGLT2i and an alternative AD (replacing GLP-1 RA) MAY BE CONSIDERED to improve glycemic control. Here, GCG is linked to type 2 diabetes mellitus.